Cargando…
Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter]
Autores principales: | Shuja, Syed Hasan, Asad, Dayab, Parekh, Abdul Samad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473843/ https://www.ncbi.nlm.nih.gov/pubmed/34588785 http://dx.doi.org/10.2147/IDR.S338460 |
Ejemplares similares
-
Role of Folate, Cobalamin, and Probiotics in COVID-19 Disease Management [Letter]
por: Asad, Dayab, et al.
Publicado: (2021) -
Factors to Weigh in While Administering Nitrous Oxide Anesthesia [Letter]
por: Shuja, Muhammad Hamza, et al.
Publicado: (2022) -
Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter]
por: Shuja, Syed Hasan, et al.
Publicado: (2021) -
Sinopharm COVID-19 vaccine-induced Stevens–Johnson syndrome
por: Boualila, L., et al.
Publicado: (2022) -
Biosimilar insulins: An unavoidable option in South-East Asia
por: Kaduskar, Prashant Ulhas
Publicado: (2016)